These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21792167)

  • 1. Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experience.
    Melloni G; Bandiera A; Gregorc V; Carretta A; Ciriaco P; Viganò M; Franzin A; Bolognesi A; Picozzi P; Zannini P
    J Cardiovasc Surg (Torino); 2011 Aug; 52(4):613-9. PubMed ID: 21792167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multimodal Treatment of Non-Small Cell Lung Cancer with Cerebral Metastases].
    Kudelin N; Bölükbas S; Schirren J
    Zentralbl Chir; 2015 Jun; 140(3):328-33. PubMed ID: 26114639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage.
    Collaud S; Stahel R; Inci I; Hillinger S; Schneiter D; Kestenholz P; Weder W
    Lung Cancer; 2012 Dec; 78(3):234-8. PubMed ID: 23040415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?
    Kim KH; Lee J; Lee JI; Nam DH; Kong DS; Ahn YC; Park HC; Kwon OJ; Kim H; Chang MH; Yi SY; Ji SH; Park YH; Ahn JS; Park K; Ahn MJ
    Lung Cancer; 2010 May; 68(2):258-63. PubMed ID: 19592127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of preoperative 18F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancer.
    Tönnies S; Tönnies M; Kollmeier J; Bauer TT; Förster GJ; Kaiser D; Wernecke KD; Pfannschmidt J
    Lung Cancer; 2016 Mar; 93():28-34. PubMed ID: 26898611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery of primary lung cancer with oligometastatic m1b synchronous single brain metastasis: analysis of 37 cases.
    Cheufou DH; Welter S; Chalvatzoulis E; Christof D; Theegarten D; Stamatis G
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):612-5. PubMed ID: 25136943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
    Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
    Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
    Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
    Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
    Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer.
    Eschmann SM; Friedel G; Paulsen F; Reimold M; Hehr T; Budach W; Langen HJ; Bares R
    Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):463-71. PubMed ID: 17103167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer.
    Bougie E; Masson-Côté L; Mathieu D
    World Neurosurg; 2015 Jun; 83(6):900-6. PubMed ID: 25659803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
    Aoyama H; Tago M; Shirato H;
    JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of radiotherapy between postoperative mediastinal lymph node recurrence and stage III disease in non-small cell lung cancer patients.
    Imai H; Murakami H; Yoshino R; Mori K; Sumita K; Ono A; Akamatsu H; Taira T; Kenmotsu H; Harada H; Naito T; Kaira K; Tomizawa Y; Ohde Y; Matsuura M; Endo M; Saito R; Nakajima T; Takahashi T
    J BUON; 2016; 21(2):333-40. PubMed ID: 27273942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: a curative approach.
    Parlak C; Mertsoylu H; Güler OC; Onal C; Topkan E
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):885-91. PubMed ID: 24495594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
    Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.